Tonix Pharmaceuticals Holding Corp. (TNXP) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 124.86M USD. 52-week range 7.16 to 22.38 USD. Trailing P/E 0.1. Data as of 2026-10-09.
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company ...